Immunogenetics of new onset diabetes after transplantation in Kuwait
Mohamed Jahromi,1 Torki Al-Otaibi,2 Nashwa Othman,3 Osama Gheith,2 Tarek Mahmoud,2 Prasad Nair,2 Medhat A Halim,2 Narayanam Nampoory1,21Clinical Research, Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait; 2Nephrology Department, Hamid Al-Essa Organ Transplant Center, Kuwait City, Kuw...
Guardado en:
Autores principales: | Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/631a534fcfea4f55bfded280e6e3da9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Lekshmy Srinivas, et al.
Publicado: (2021) -
New onset diabetes after transplantation (NODAT): an overview
por: Pham PT, et al.
Publicado: (2011) -
Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review
por: Alexis H. Lerner, et al.
Publicado: (2021) -
Clinical and preclinical tolerance protocols for vascularized composite allograft transplantation
por: Jerry Huanda Yang, et al.
Publicado: (2021) -
Histocompatibility and Immunogenetics in Cord Blood Transplantation
por: Rubinstein,Pablo, et al.
Publicado: (2010)